Table 3.
Treatments and outcomes.
| Total N = 160 | Cases N = 80 | Controls N = 80 | P value | |
|---|---|---|---|---|
| Lopinavir/ritonavir, n (%) | 17 (10.6%) | 5 (6.3%) | 12 (15.0%) | 0.06 |
| Remdesivir, n (%) | 0 | 0 | 0 | – |
| Hydroxychloroquine, n (%) | 39 (24.5%) | 19 (23.8%) | 20 (25.3%) | 0.78 |
| Macrolides, n (%) | 70 (43.8%) | 34 (42.5%) | 36 (45.0%) | 0.68 |
| Corticosteroids, n (%) | 10 (6.3%) | 6 (7.5%) | 4 (5.0%) | 0.53 |
| Tocilizumab, n (%) | 3 (1.9%) | 1 (1.3%) | 2 (2.5%) | 0.57 |
| At least one treatment, n (%) | 62 (38.8%) | 28 (35.0%) | 34 (42.5%) | 0.26 |
| Outcome at hospital discharge | ||||
| Discharged alive | 135 (85.4%) | 68 (86.1%) | 67 (84.8%) | 0.80 |
| Died | 23 (14.6%) | 11 (13.9%) | 12 (15.2%) | |
| Time from hospital admission to death, days, median [IQR] | 9.0 [5.0; 17.0] | 10.0 [6.0; 23.0] | 6.5 [4.5; 16.5] | 0.66 |
| Hospital stay length, days, median [IQR] | 8.0 [4.0; 15.0] | 8.0 [4.5; 16.0] | 8.5 [4.0; 15.0] | 0.72 |
| Time from hospital admission to hospital discharge or death, days, median [IQR] | 8.0 [5.0; 16.0] | 8.0 [5.0; 17.0] | 8.0 [4.0; 16.0] | 0.54 |
| Mechanical ventilation, n (%) | 24 (15.2%) | 10 (12.7%) | 14 (17.7%) | 0.17 |
| Duration of mechanical ventilation, days, median [IQR] | 18.0 [11.0; 27.0] | 21.5 [16.0; 35.0] | 15.5 [5.0; 21.0] | 0.19 |
| ARDS, n (%) | 29 (18.7%) | 14 (18.4%) | 15 (19; 0%) | 0.59 |
| Grade of ARDS, n (%) | ||||
| Mild | 2 (6.9%) | 2 (14.3%) | 0 | 0.65 |
| Moderate | 9 (31.0%) | 3 (21.4%) | 6 (40.0%) | |
| Severe | 18 (62.1%) | 9 (64.3%) | 9 (60.0%) | |
IQR interquartile range, ARDS acute respiratory distress syndrome.